No Data
No Data
Lepu Healthcare (300003): 2024Q1 month-on-month improvement, optimistic that the company's innovative products will continue to reap
Key investment points: The 2023 performance fell short of expectations, and the 2024 month-on-month recovery: the company released the 2023 annual report. During the reporting period, it achieved operating income of 7.98 billion yuan, a year-on-year decrease of 25%; achieved net profit to mother of 12.58
Lepu Healthcare (300003): The 24Q1 business trend is improving, and innovative products are growing steadily
Lepu Healthcare announced its 2023 annual report. In 2023, the company achieved operating income of 7.980 billion yuan (year-on-year decrease of 24.78%); realized net profit to mother of 1,258 billion yuan (year-on-year decrease of 42.91%); actual
Revenue Miss: Lepu Medical Technology (Beijing) Co., Ltd. Fell 13% Short Of Analyst Revenue Estimates And Analysts Have Been Revising Their Models
It's shaping up to be a tough period for Lepu Medical Technology (Beijing) Co., Ltd. (SZSE:300003), which a week ago released some disappointing quarterly results that could have a notable impact on h
Lepu Healthcare (300003): Overall performance is under pressure in the short term, optimistic that innovative businesses such as structural innovation will lead to a continuous recovery in performance
Event: The company released the 2023 annual report and the first quarter report of 2024. The full year of 2023 achieved operating income of 7.980 billion yuan (YoY -24.78%) and net profit of 1,258 billion yuan (YoY)
Lepu Healthcare (300003): Apparent performance is under pressure, optimistic that innovation will drive profit improvement
Event: The company released its 2023 annual report and 2024 quarterly report. In 2023, it achieved operating income of 7.980 billion yuan (-24.78%) and net profit to mother of 1,258 billion yuan (-42.91%),
Lepu Healthcare (300003): Performance continues to be under pressure, focus on subsequent marginal improvements
2023 and 1Q24 results fell short of our expectations The company announced full-year 2023 and 1Q24 results. 2023 revenue of $7.980 billion, -25% YoY, net of non-net profit of $1,123 million, YoY
No Data